首页> 外文期刊>Molecular medicine reports >Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor
【24h】

Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor

机译:结直肠癌干细胞和化学耐药性结直肠癌细胞表型以及对Notch通路抑制剂的敏感性增加

获取原文
获取原文并翻译 | 示例
       

摘要

Colorectal cancer stem cells (Co-CSCs) are a small subpopulation of tumor cells which have been proposed to be tumor-initiating cells in colorectal cancer (CRC) and to be implicated in resistance to standard chemotherapy. Chemoresistance is a common problem in the clinic. However, the interrelation between Co-CSCs and chemoresistant cells has yet to be elucidated. The present study investigated the Co-CSC phenotype in colonospheres and chemoresistant CRC cell lines and aimed to identify targets for therapy. Colonospheres and chemoresistant CRC cells were found to be enriched with the CSC markers CD133 and CD44, and exhibited similar phenotypes. Furthermore, it was found that Notch signaling may simultaneously regulate Co-CSCs and chemoresistant cells and may represent a novel strategy for targeting this pathway in CRC.
机译:结直肠癌干细胞(Co-CSCs)是肿瘤细胞的一小部分亚群,已被提出是结直肠癌(CRC)中的肿瘤起始细胞,并涉及对标准化学疗法的耐药性。化学抗性是临床中的常见问题。但是,Co-CSC与化学抗性细胞之间的相互关系尚未阐明。本研究调查了结肠球和化学抗性CRC细胞系中的Co-CSC表型,旨在确定治疗靶点。发现结肠球和化学抗性CRC细胞富含CSC标记CD133和CD44,并表现出相似的表型。此外,已发现Notch信号传导可同时调节Co-CSC和化学抗性细胞,并且可代表靶向CRC中该途径的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号